MENU
+Compare
PSTV
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.17
Change
-$0.02 (-1.68%)
Capitalization
6.9M

PSTV Plus Therapeutics Forecast, Technical & Fundamental Analysis

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PSTV with price predictions
Jan 08, 2025

PSTV in -4.76% downward trend, falling for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PSTV declined for three days, in of 302 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

PSTV moved below its 50-day moving average on January 07, 2025 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PSTV's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on PSTV as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PSTV just turned positive on December 31, 2024. Looking at past instances where PSTV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PSTV advanced for three days, in of 243 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). PSTV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PSTV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PSTV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PSTV is expected to report earnings to fall 12.50% to -12 cents per share on August 16

Plus Therapeutics PSTV Stock Earnings Reports
Q2'23
Est.
$-0.12
Q1'23
Est.
$-0.14
Q4'22
Missed
by $0.62
Q3'22
Beat
by $0.01
Q2'22
Missed
by $0.02
The last earnings report on April 20 showed earnings per share of -14 cents, meeting the estimate of -14 cents. With 8.78K shares outstanding, the current market capitalization sits at 6.90M.
A.I. Advisor
published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERU0.980.13
+15.61%
Veru
ALZN1.160.01
+0.87%
Alzamend Neuro Inc.
RYI20.760.10
+0.48%
RYERSON HOLDING Corp
NHI69.320.06
+0.09%
National Health Investors
SAIA486.89-6.15
-1.25%
Saia

PSTV and Stocks

Correlation & Price change

A.I.dvisor tells us that PSTV and DRUG have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSTV and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTV
1D Price
Change %
PSTV100%
-1.69%
DRUG - PSTV
33%
Poorly correlated
+0.49%
PBIGF - PSTV
29%
Poorly correlated
+1.18%
ZYME - PSTV
28%
Poorly correlated
-0.79%
ARRY - PSTV
27%
Poorly correlated
-0.14%
CRIS - PSTV
26%
Poorly correlated
+3.46%
More